Volume 64, Issue 3, Pages (September 2013)

Slides:



Advertisements
Similar presentations
Maria Carmen Mir, Cesar Ercole, Andrew Stephenson
Advertisements

Volume 60, Issue 5, Pages (November 2011)
The PSA Era is not Over for Prostate Cancer
Volume 64, Issue 3, Pages (September 2013)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 63, Issue 5, Pages (May 2013)
Global Trends in Testicular Cancer Incidence and Mortality
Volume 65, Issue 4, Pages (April 2014)
Volume 73, Issue 1, Pages (January 2018)
Volume 61, Issue 5, Pages (May 2012)
Volume 53, Issue 5, Pages (May 2008)
Control of Prostate Cancer by Transrectal HIFU in 227 Patients
Volume 66, Issue 3, Pages (September 2014)
Volume 50, Issue 5, Pages (November 2006)
Volume 68, Issue 3, Pages (September 2015)
Volume 53, Issue 5, Pages (May 2008)
Volume 66, Issue 6, Pages (December 2014)
Volume 71, Issue 6, Pages e171-e172 (June 2017)
Let the Games Begin (with EAU Approval)
Volume 64, Issue 3, Pages (September 2013)
Volume 72, Issue 5, Pages (November 2017)
Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?
Prostate Cancer Epidemic in Sight?
Volume 74, Issue 1, Pages (July 2018)
European Urology Oncology
Bladder Cancer: A Major Public Health Issue
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 61, Issue 5, Pages (May 2012)
Volume 61, Issue 4, Pages (April 2012)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Prostate Cancer Detection: A View of the Future
Volume 68, Issue 3, Pages (September 2015)
P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes  European Urology 
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 68, Issue 1, Pages (July 2015)
Volume 61, Issue 6, Pages (June 2012)
Volume 63, Issue 5, Pages (May 2013)
Volume 69, Issue 3, Pages (March 2016)
European Urology Oncology
Volume 72, Issue 3, Pages (September 2017)
Volume 57, Issue 4, Pages e41-e42 (April 2010)
Counselling the Prostate Cancer Patient
Volume 56, Issue 6, Pages (December 2009)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 66, Issue 6, Pages (December 2014)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
The Economic Costs of Overactive Bladder in Germany
Volume 53, Issue 1, Pages (January 2008)
Volume 69, Issue 6, Pages (June 2016)
Volume 62, Issue 3, Pages (September 2012)
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Testicular Cancer Variations in Time and Space in Europe
Prognostic Impact of Comorbidity in Patients with Bladder Cancer
European Urology is “Your” Journal
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
Economic Burden of Bladder Cancer Across the European Union
Volume 52, Issue 4, Pages (October 2007)
Prognostic Factors in Non–Muscle-Invasive Bladder Tumors
Volume 53, Issue 6, Pages (June 2008)
Volume 53, Issue 2, Pages (February 2008)
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 64, Issue 3, Pages 355-357 (September 2013) Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Which Patients Benefit?  Günter Niegisch, Anja Lorch, Michael J. Droller, Hugh J. Lavery, Kristian D. Stensland, Peter Albers  European Urology  Volume 64, Issue 3, Pages 355-357 (September 2013) DOI: 10.1016/j.eururo.2013.06.002 Copyright © 2013 European Association of Urology Terms and Conditions

Fig. 1 Proposed clinical decision pathway for neoadjuvant chemotherapy in patients with urothelial cancer of the bladder. GC=gemcitabine and cisplatin. European Urology 2013 64, 355-357DOI: (10.1016/j.eururo.2013.06.002) Copyright © 2013 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.